Judith C. van Deutekom

2.3k citations

15 papers · 1.8k indexed · 2 hit papers · h-index 12

Genetics top 2%
- Virus-based gene therapy research 3
- Neurogenetic and Muscular Disorders Research 3
Molecular Biology top 5%
- Muscle Physiology and Disorders 13
- RNA Interference and Gene Delivery 3
Cardiology and Cardiovascular Medicine top 5%
- Cardiomyopathy and Myosin Studies 4
- Viral Infections and Immunology Research 3
Genetics top 5%
- Virus-based gene therapy research 3
- Neurogenetic and Muscular Disorders Research 3
Cellular and Molecular Neuroscience top 10%
Physiology
- Telomeres, Telomerase, and Senescence 3
Biomedical Engineering
- Advanced Sensor and Energy Harvesting Materials 3

Co-authors: Annemieke Aartsma‐Rus Anneke A. M. Janson Sjef J. de Kimpe Jan J.G.M. Verschuuren Nathalie Goemans Gert‐Jan B. van Ommen Gerard Platenburg Johan T. den Dunnen
Cited by: Genetics Molecular Biology Cardiology and Cardiovascular Medicine
Journals: New England Journal of Medicine (2 papers)PLoS ONE (3 papers)Scientific Reports (1 paper)
Partner nations: Netherlands Sweden United Kingdom

In The Last Decade

Judith C. van Deutekom

15 papers receiving 1.7k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Judith C. van Deutekom

Since Specialization

Citations

This map shows the geographic impact of Judith C. van Deutekom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith C. van Deutekom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith C. van Deutekom more than expected).

Fields of papers citing papers by Judith C. van Deutekom

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith C. van Deutekom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith C. van Deutekom. The network helps show where Judith C. van Deutekom may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Judith C. van Deutekom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Judith C. van Deutekom Line = papers co-authored together Judith C. van Deutekom links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work
1	Low dystrophin variability between muscles and stable expression over time in Becker muscular dystrophy using capillary Western immunoassay Scientific Reports ·Zaïda Koeks,Annika Janson,Chantal Beekman,Mirko Signorelli,Hermine A. van Duyvenvoorde,J.C. van den Bergen,Melissa T. Hooijmans,Iris Alleman,Ingrid M. Hegeman,Jan J.G.M. Verschuuren,Judith C. van Deutekom,Pietro Spitali,Nicole A. Datson,E. Niks	2021	13
2	Using a State-of-the-Art Toolbox to Evaluate Molecular and Functional Readouts of Antisense Oligonucleotide-Induced Exon Skipping in mdx Mice Nucleic Acid Therapeutics ·Nicole A. Datson,Suzanne Bijl,Anneke A. M. Janson,Janwillem Testerink,Rani van den Eijnde,Rudie Weij,Jukka Puoliväli,Kimmo Lehtimäki,Timo Bragge,Toni Ahtoniemi,Judith C. van Deutekom	2019	6
3	Use of capillary Western immunoassay (Wes) for quantification of dystrophin levels in skeletal muscle of healthy controls and individuals with Becker and Duchenne muscular dystrophy PLoS ONE ·Chantal Beekman,Anneke A. M. Janson,Aabed Baghat,Judith C. van Deutekom,Nicole A. Datson	2018	86
4	Long-Term Efficacy, Safety, and Pharmacokinetics of Drisapersen in Duchenne Muscular Dystrophy: Results from an Open-Label Extension Study PLoS ONE ·Nathalie Goemans,M. Tulinius,M. van den Hauwe,Anna‐Karin Kroksmark,Gunnar Buyse,Rosamund Wilson,Judith C. van Deutekom,Sjef J. de Kimpe,Afrodite Lourbakos,Giles Campion	2016	66
5	A Sensitive, Reproducible and Objective Immunofluorescence Analysis Method of Dystrophin in Individual Fibers in Samples from Patients with Duchenne Muscular Dystrophy PLoS ONE ·Chantal Beekman,Jessica A. Sipkens,Janwillem Testerink,Stavros Giannakopoulos,Kreuger Dyonne,Judith C. van Deutekom,G. Campion,Sjef J. de Kimpe,Afrodite Lourbakos	2014	33
6	Dystrophin levels and clinical severity in Becker muscular dystrophy patients Journal of Neurology Neurosurgery & Psychiatry ·J.C. van den Bergen,Beatrijs Wokke,Annika Janson,Sjoerd G. van Duinen,Margriet Hulsker,H.B. Ginjaar,Judith C. van Deutekom,Annemieke Aartsma‐Rus,Hermien E. Kan,Jan J.G.M. Verschuuren	2013	94
7	Design and Analysis of Effects of Triplet Repeat Oligonucleotides in Cell Models for Myotonic Dystrophy Molecular Therapy — Nucleic Acids ·Anchel González‐Barriga,Susan Mulders,Jeroen van de Giessen,Jeroen D Hooijer,Suzanne Bijl,Ingeborg DG van Kessel,Josee van Beers,Judith C. van Deutekom,Jack Fransen,Bé Wieringa,Derick G. Wansink	2013	36
8	Antisense oligonucleotides as personalized medicine for Duchenne muscular dystrophy Drug Discovery Today Therapeutic Strategies ·Judith C. van Deutekom,Sjef J. de Kimpe,G. Campion	2013	6
9	Exon skipping for DMD Orphanet Journal of Rare Diseases ·Annemieke Aartsma‐Rus,Jan J.G.M. Verschuuren,G. Campion,Gert‐Jan B. van Ommen,Judith C. van Deutekom	2012	2
10	Systemic Administration of PRO051 in Duchenne's Muscular Dystrophybreakdown → New England Journal of Medicine ·Nathalie Goemans,M. Tulinius,Johanna T. van den Akker,Brigitte E. Burm,Peter F. Ekhart,Niki Heuvelmans,Tjadine M. Holling,Anneke A. M. Janson,Gerard Platenburg,Jessica A. Sipkens,J. M. A. Sitsen,Annemieke Aartsma‐Rus,Gert‐Jan B. van Ommen,Gunnar Buyse,Niklas Darín,Jan J.G.M. Verschuuren,G. Campion,Sjef J. de Kimpe,Judith C. van Deutekom	2011	518
11	Preclinical PK and PD Studies on 2′-O-Methyl-phosphorothioate RNA Antisense Oligonucleotides in the mdx Mouse Model Molecular Therapy ·Hans Heemskerk,Christa de Winter,Petra van Kuik,Niki Heuvelmans,Patrizia Sabatelli,Paola Rimessi,Paola Braghetta,Gert‐Jan B. van Ommen,S. de Kimpe,Alessandra Ferlini,Annemieke Aartsma‐Rus,Judith C. van Deutekom	2010	114
12	Local Dystrophin Restoration with Antisense Oligonucleotide PRO051breakdown → New England Journal of Medicine ·Judith C. van Deutekom,Anneke A. M. Janson,Ieke B. Ginjaar,Wendy S. Frankhuizen,Annemieke Aartsma‐Rus,Mattie Bremmer-Bout,Johan T. den Dunnen,Klaas Koop,Anneke J. van der Kooi,Nathalie Goemans,Sjef J. de Kimpe,Peter F. Ekhart,Edna H. Venneker,Gerard Platenburg,Jan J.G.M. Verschuuren,Gert‐Jan B. van Ommen	2007	577
13	Comparative Analysis of Antisense Oligonucleotide Sequences for Targeted Skipping of Exon 51 During Dystrophin Pre-mRNA Splicing in Human Muscle Human Gene Therapy ·Virginia Arechavala‐Gomeza,Ian R. Graham,Linda Popplewell,A.M. Adams,Annemieke Aartsma‐Rus,Maria Kinali,Jennifer E. Morgan,Judith C. van Deutekom,Steve D. Wilton,George Dickson,Francesco Muntoni	2007	123
14	Dystrophin nonsense mutation induces different levels of exon 29 skipping and leads to variable phenotypes within one BMD family European Journal of Human Genetics ·Ieke B. Ginjaar,Alexander L.J. Kneppers,Jan-Douwe M v d Meulen,Louise V.B. Anderson,Mattie Bremmer-Bout,Judith C. van Deutekom,Jitske Weegenaar,Johan T. den Dunnen,Egbert Bakker	2000	73
15	Mutation in DHP receptor alpha 1 subunit (CACLN1A3) gene in a Dutch family with hypokalaemic periodic paralysis. Journal of Medical Genetics ·R.H. Boerman,R. A. Ophoff,Thera P. Links,Ronald van Eijk,Lodewijk A. Sandkuijl,Alexis Elbaz,J. Vale-Santos,Axel R. Wintzen,Judith C. van Deutekom,D E Isles	1995	23

About Judith C. van Deutekom

Judith C. van Deutekom is a scholar working on Cardiology and Cardiovascular Medicine, Genetics and Physiology, having authored 15 papers that have together received 1.8k indexed citations. Recurring topics across this work include Muscle Physiology and Disorders (13 papers), Cardiomyopathy and Myosin Studies (4 papers), Viral Infections and Immunology Research (3 papers), Virus-based gene therapy research (3 papers), RNA Interference and Gene Delivery (3 papers), Telomeres, Telomerase, and Senescence (3 papers), Neurogenetic and Muscular Disorders Research (3 papers) and Advanced Sensor and Energy Harvesting Materials (3 papers). The work is most often cited by research in Genetics (393 citations), Molecular Biology (1.7k citations) and Cardiology and Cardiovascular Medicine (335 citations). Judith C. van Deutekom has collaborated with scholars based in Netherlands, Sweden and United Kingdom. Frequent co-authors include Annemieke Aartsma‐Rus, Anneke A. M. Janson, Sjef J. de Kimpe, Jan J.G.M. Verschuuren, Nathalie Goemans, Gert‐Jan B. van Ommen, Gerard Platenburg, Johan T. den Dunnen, Ieke B. Ginjaar and Klaas Koop. Their work appears in journals such as New England Journal of Medicine, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact